BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26408540)

  • 1. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
    Yoshioka K; Otani H; Shimazu T; Fujita M; Iwasaka T; Shiojima I
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1782-91. PubMed ID: 26408540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.
    Takimoto E; Champion HC; Li M; Ren S; Rodriguez ER; Tavazzi B; Lazzarino G; Paolocci N; Gabrielson KL; Wang Y; Kass DA
    J Clin Invest; 2005 May; 115(5):1221-31. PubMed ID: 15841206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
    Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling.
    Hashimoto T; Sivakumaran V; Carnicer R; Zhu G; Hahn VS; Bedja D; Recalde A; Duglan D; Channon KM; Casadei B; Kass DA
    J Am Heart Assoc; 2016 Mar; 5(3):e003208. PubMed ID: 27001967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance.
    Kurtz B; Thibault HB; Raher MJ; Popovich JR; Cawley S; Atochin DN; Hayton S; Shakartzi HR; Huang PL; Bloch KD; Buys E; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2093-101. PubMed ID: 21856905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.
    Ichinose F; Bloch KD; Wu JC; Hataishi R; Aretz HT; Picard MH; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1070-5. PubMed ID: 14644766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rats are protected from the stress of chronic pressure overload compared with mice.
    Nishimura K; Oydanich M; Zhang J; Babici D; Fraidenraich D; Vatner DE; Vatner SF
    Am J Physiol Regul Integr Comp Physiol; 2020 May; 318(5):R894-R900. PubMed ID: 32209023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
    You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.
    Moens AL; Leyton-Mange JS; Niu X; Yang R; Cingolani O; Arkenbout EK; Champion HC; Bedja D; Gabrielson KL; Chen J; Xia Y; Hale AB; Channon KM; Halushka MK; Barker N; Wuyts FL; Kaminski PM; Wolin MS; Kass DA; Barouch LA
    J Mol Cell Cardiol; 2009 Nov; 47(5):576-85. PubMed ID: 19766235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
    Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial reverse remodeling after pressure unloading is associated with maintained cardiac mechanoenergetics in a rat model of left ventricular hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Li S; Németh BT; Hegedűs P; Brlecic P; Mátyás C; Zorn M; Merkely B; Karck M; Radovits T; Szabó G
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H592-603. PubMed ID: 27342874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
    Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
    J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matúsková J; Lupták I; Pincíková T; Krajcírovicová K; Stvrtina S; Pomsár J; Pelouch V; Paulis L; Pechánová O
    Physiol Res; 2007; 56 Suppl 2():S25-S32. PubMed ID: 17824810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.
    Buys ES; Raher MJ; Blake SL; Neilan TG; Graveline AR; Passeri JJ; Llano M; Perez-Sanz TM; Ichinose F; Janssens S; Zapol WM; Picard MH; Bloch KD; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H620-7. PubMed ID: 17416602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
    Deng J; Wang YW; Chen WM; Wu Q; Huang XN
    Biol Pharm Bull; 2010; 33(4):631-5. PubMed ID: 20410597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.